The interaction of an optically pure benzomorphan opiate, (-)-N-allyl-N-normetazocine [(-)-ANMC], with the nicotinic acetylcholine receptor from Torpedo electroplaque was studied by using radioligand binding and affinity labeling. The binding was complex with at least two specific components having equilibrium dissociation constants of 0.3 jiM and 2 jiM. The affinity of the higher affinity component was decreased by carbamoylcholine but not by a-bungarotoxin. The effect of carbamoylcholine was not blocked by abungarotoxin. In comparison, the affinity of [3Hlphencycli-dine, a well-characterized ligand for a high-affinity site for noncompetitive blockers on the acetylcholine receptor, is increased by carbamoylcholine and the increase is blocked by abungarotoxin. The binding of (-)-[3HJANMC was inhibited by a number of other benzomorphans, with (-) isomers being 4-to 5-fold more potent than (+) isomers. Phencyclidine inhibits the binding of (-)-[3H]ANMC to its high-affinity site by a mechanism that is not competitive. UV-catalyzed affinity labeling indicated that the high-affinity-binding site for (-)- 
its the binding of (-)-[3H]ANMC to its high-affinity site by a mechanism that is not competitive. UV-catalyzed affinity labeling indicated that the high-affinity-binding site for (-)-[3H]ANMC is at least partially associated with the 8 subunit. Tryptic degradation of the Torpedo marmorata 8 chain suggested that (-)-ANMC labeled a 16,000-dalton COOH-terminal portion of the subunit. In contrast, 5-azido-[3Hltrimethiso-quin, a photoaffinity label of the high-affinity site for noncompetitive blockers, labels a 47,000-dalton N1H2-terminal fragment of the 8 subunit. These results suggest that (-)-[3HJANMC binds to sites completely distinct from the binding sites for acetylcholine. The high-affinity-binding site for (-)-ANMC and that for phencyclidine and 5-azidotrimethisoquin are allosterically coupled but are regulated differently and are probably physically distinct.
The nicotinic acetylcholine receptor (AcChoR) from Torpedo electroplaque is a multisubunit protein that mediates ion flux across the cell membrane in response to the binding of acetylcholine (AcCho). The (2) (3) (4) . These subunits migrate in NaDodSO4/polyacrylamide gels with apparent molecular masses of 40,000, 50,000, 60,000, and 66,000 daltons, respectively. A high-affinity-binding site for AcCho is associated, at least in part, with each of the a subunits (reviewed in ref. 5 ). In addition, a series of compounds, known collectively as noncompetitive blockers, has been shown to bind to the AcChoR (6) (7) (8) (9) (10) (11) (12) (13) . These compounds, which include phencyclidine (PCP), histrionicotoxin, chlorpromazine, and some aminated local anesthetics, bind to one high-affinity site per AcChoR monomer (reviewed in ref. 14) as well as to a variable number of low-affinity sites associated with the membrane lipids (10, 11 (18, 19) . In the present studies, a radioactive optically pure benzomorphan,
used to measure reversible binding to and affinity labeling of the Torpedo electroplaque AcChoR. Specific binding was shown to be complex with at least one component having lower affinity in the presence rather than the absence of cholinergic effectors. Binding to the high-affinity site was inhibited by PCP with a mechanism that is not competitive. aBungarotoxin (a-BuTx) had no effect on the decrease in affinity induced by cholinergic effectors. UV-catalyzed affinity labeling (20) resulted in the labeling of the 8 subunit and, in some cases, the a subunit. these results may indicate a unique binding site for benzomorphans on the AcChoR.
MATERIALS AD METHODS
AcChoR-rich membranes were prepared from the electroplaque of Torpedo californica, Torpedo marmorata, and Torpedo nobiliana as described (21) . The binding of (-)-
[3H]ANMC was measured by either a centrifugation (10) or a filtration assay (22, 23) Interaction Between Sites for a-BuTx and (-)-ANMC. The effect of (-)-ANMC on the initial rate of binding of 15 nM I-a-BuTx to AcChoR-rich membrane fragments (5 nM in 125I-a-BuTx sites) was measured. The IC 0 for (-)-ANMC was 440 ALM, indicating that the sites described in Figs. 1 Fig. 4 shows the labeling of peptides from T. nobiliana AcChoR-rich membrane fragments. Approximately 60% of the specifically bound radioactivity measured by a filtration assay was incorporated into the sub unit. Consistent with the reversible binding of (-)-[3H]ANMC (Fig. 2) , carbamoylcholine decreases the labeling of the subunit (Fig. 4, (Fig. 5) . The 
NH2-terminal fragments. The labeling of the 8 chain by (-)-
[3H]ANMC does not appear in the NH2-terminal tryptic fragments of the 8 chain (Fig. 5) . Instead, the site of (-)- (29, 30) , although the comparison with the present results is not clear. The noncompetitive interaction between the high-affinity (-)-ANMC site and the PCP site, the differential regulation by cholinergic effectors, and the differential affinity labeling results (see below) suggest that the binding site for PCP and the high-affinity-binding site for (-)-ANMC are distinct. The competitive interaction between the low-affinity site for (-)-ANMC and for the site for PCP suggests that these sites may be identical. The weak inhibition of the initial rate of a-BuTx binding by (-)-ANMC and the heat sensitivity of both (-)-ANMC sites indicate that these sites are neither the high-affinity sites for AcCho and a-BuTx nor the lipid-associated sites reported previously for some noncompetitive blockers (10) .
The UV-catalyzed cross-linking of (-) The site of labeling on the T. marmorata 8 chain may be on a 16,000-dalton COOH-terminal portion of the subunit that also contains a cysteine, which is thought to be involved in disulfide-linked dimers of the receptor (25) . This portion of the subunit most likely includes the 12,000-dalton tryptic peptide described by Anderson et al. (31) , which contains the major antigenic sites on the 8 subunit.
In conclusion, the benzomorphan (-)-ANMC has been shown to bind stereoselectively to the nicotinic AcChoR. The high-affinity-binding site is regulated by cholinergic effectors in a manner opposite to that of PCP and most other noncompetitive blockers and is allosterically coupled to the PCP site. Affinity labeling suggests that PCP and other noncompetitive blockers interact with a site distinct from that for (-)-ANMC. These results indicate that benzomorphan opiates bind to a unique site on the AcChoR.
